Uscom Limited (ASX:UCM)
0.0250
0.00 (0.00%)
Apr 17, 2025, 3:54 PM AEST
Uscom Revenue
Uscom had revenue of 1.86M AUD in the half year ending December 31, 2024, with 47.86% growth. This brings the company's revenue in the last twelve months to 3.63M, up 8.01% year-over-year. In the fiscal year ending June 30, 2024, Uscom had annual revenue of 3.73M with 39.89% growth.
Revenue (ttm)
3.63M
Revenue Growth
+8.01%
P/S Ratio
1.72
Revenue / Employee
103.74K
Employees
35
Market Cap
6.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.73M | 1.06M | 39.89% |
Jun 30, 2023 | 2.66M | 154.48K | 6.16% |
Jun 30, 2022 | 2.51M | -1.35M | -34.95% |
Jun 30, 2021 | 3.86M | -426.65K | -9.96% |
Jun 30, 2020 | 4.28M | 642.77K | 17.65% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |